Cargando…
Therapeutic potential of targeting kinase inhibition in patients with idiopathic pulmonary fibrosis
Fibrosis is characterized by excessive accumulation of extracellular matrix components. The fibrotic process ultimately leads to organ dysfunction and failure in chronic inflammatory and metabolic diseases such as pulmonary fibrosis, advanced kidney disease, and liver cirrhosis. Idiopathic pulmonary...
Autores principales: | Kim, Suji, Lim, Jae Hyang, Woo, Chang-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yeungnam University College of Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606966/ https://www.ncbi.nlm.nih.gov/pubmed/32693446 http://dx.doi.org/10.12701/yujm.2020.00458 |
Ejemplares similares
-
Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis()
por: Sehgal, Manas, et al.
Publicado: (2022) -
Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022) -
CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
por: Liu, Shanshan, et al.
Publicado: (2023) -
Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015) -
Update on therapeutic management of idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2015)